Navigation Links
The Leukemia & Lymphoma Society: Accelerating Cures Must Be a Priority
Date:4/1/2011

WHITE PLAINS, N.Y., April 1, 2011 /PRNewswire/ -- Once again, the Annual Report to the Nation on the Status of Cancer shows a continued decline in diagnoses and deaths for many types of cancers. This encouraging news can be attributed primarily to preventive measures such as cessation of smoking and improved diet, and early detection.

(Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO)

But for many cancers, such as the blood cancers, early detection is rare, there are no measures that can be taken to prevent the onset of the disease, and they are still killing too many. In these cases, the only solution is continued research to find better treatments and cures once the diagnosis is made.

It is for this reason that many voluntary disease organizations have created programs to accelerate therapies from laboratories to patients. We recognize that funding research is costly and difficult, particularly in these trying economic times, particularly for orphan diseases such as blood cancers where producing these treatments may not always be cost-effective for drug companies.

We have to be more proactive and innovative in our approaches to funding drug development, not only funding laboratory research, but also partnering with biotechnology companies on high-prospect research projects, or by providing much needed expertise to help academics bring their discoveries to market.  We are continually searching for new ways to ensure that scientific discoveries are not stuck collecting dust on academic shelves, but are given the boost they need to cross the chasm that swallows so many promising findings.

The Federal government also recognizes this need to get more treatments to patients faster.  A key provision of the federal Affordable Care Act that has received little attention is the creation by Congress of the Cures Acceleration Network (CAN). This program, which would be administered by Frances Collins, Ph.D.,
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias
2. Alfacells ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells
3. In 2008, Ipsogen Reinforced its Leadership in Molecular Diagnosis and Monitoring of Leukemia
4. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
5. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
6. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
7. Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma
8. Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress
9. The Leukemia & Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research
10. Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
11. Childrens Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  Alternative Energy & Environmental ... has signed a letter of intent to acquire ... and patented a nanotechnology-based development platform used to ... enable rapid on-site collection and testing to identify ... issues in an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... 19, 2014 Naurex Inc., a biopharmaceutical company ... diseases of the central nervous system, today announced that ... officer, will present at the 33 rd annual ... place at 3:00 p.m. PST on Tuesday, January 13, ... San Francisco, Calif. About ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... ... CEO Sally Van Doren, PharmD, will present at the 9th DIA Conference for Contemporary Pharmacovigilance ... Van Doren will present on the topic of the Integrated Summary of Safety. , ... Emeryville, CA (PRWEB) November 18, 2009 ...
... 17 November 2009 - Monetary gain stimulates activity in the ... known to activate an area of the brain called the ... 2010 issue of Cortex , published by ... striatum activation in volunteers performing a monetary task and found ...
... , HAIKOU CITY, China, Nov. ... CPHI ), which develops,manufactures, and markets specialty pharmaceutical products ... Murray, Carret & Co. 2009 China,Growth Conference, to be held ... Management is scheduled to present at 4:20 pm ET ...
Cached Biology Technology:BioSoteria CEO to Present at Drug Safety Conference 2Monetary gain and high-risk tactics stimulate activity in the brain 2China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference 2
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a leading ... that its DigitalPersona ® Pro Enterprise software ... been deployed throughout First Bank branch locations in ... South Carolina and Virginia. First Bank, a ... Southern Pines, North Carolina , selected the ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... YORK (Jan. 23, 2009) Actor and pancreatic cancer ... result of his compromised immune system underscores the sensitivity ... of a disease, rather than the disease itself. ... like an open wound. Consequently, the body has developed ...
... CAMBRIDGE, Mass., Jan. 22, 2009 -- Bioengineers at Harvard ... tumor-specific antigens and implanted under the skin can reprogram ... research -- which ridded 90 percent of mice of ... the rodents within 25 days -- represents the most ...
... PROVIDENCE, R.I. [Brown University] Brown University researchers have ... the aging process. The finding by Stephen Helfand ... the puzzle that Helfand, a professor of biology, molecular ... Back then, he identified a mutation in the Indy ...
Cached Biology News:Research elucidates way lungs fight bacteria and prevent infection 2Implants mimic infection to rally immune system against tumors 2Scientists unlock possible aging secret in genetically altered fruit fly 2
...
Small bottle for hybridization 150 x 35mm...
... is a powerful technology platform that automates ... High quality sample preparation can be ... The Xcise is a powerful technology platform ... proteome analysis. It combines the functions of ...
... Acquire images with any of UVP's ... load the Doc-It 1D Analysis software onto ... many image analysis functions and enhancement tools. ... and band finding algorithms for quick and ...
Biology Products: